- Delta eyes Election Day travel pullback as profits climb
- Florida battered by hurricane, floods but spared 'worst-case scenario'
- UK's William and Kate in first joint public engagement since cancer treatment
- Over 200 women in legal talks with Harrods over Fayed abuse claims
- A very stiff breeze: BBC says sorry for 20,000 kph wind forecast
- Musk finally unveiling his long-promised robotaxi
- London's Frieze art fair goes potty for ceramics
- US, Europe stocks fall on US inflation data
- US consumer inflation eases to 2.4% in September
- Hurricane Milton tornadoes kill four in Florida amid rescue efforts
- South Korea's Han Kang wins literature Nobel
- Ikea posts fall in annual sales after lowering prices
- Stock markets diverge, oil gains after China rebounds
- World can't 'waste time' trading climate change blame: COP29 hosts
- South Korean same-sex couples make push for marriage equality
- Mumbai declares day of mourning for Indian industrialist Ratan Tata
- 7-Eleven owner restructures to fight takeover
- Sri Lanka recovering faster than expected: World Bank
- Hong Kong, Shanghai rally as most markets track Wall St record
- Uniqlo owner reports record annual earnings
- Hong Kong, Shanghai rally as markets track Wall St record
- Indonesia biomass drive threatens key forests: report
- Mumbai mourns Indian industrialist Ratan Tata
- China opens $71 bn 'swap facility' to boost markets
- Asian markets track Wall St record as Hong Kong, Shanghai stabilise
- 'Denying my potential': women at Japan's top university call out gender imbalance
- China's central bank says opens up $70.6 bn in liquidity to boost market
- Youth facing unprecedented wave of violence, UN envoy warns
- 'A casino in every kitchen': Brazil's online gambling craze
- Nobel chemistry winner sees engineered proteins solving tough problems
- Discord seen as online home for renegades
- US forecasts severe solar storm starting Thursday
- Ratan Tata: Indian mogul who built a global powerhouse
- One dead as storm Kirk tears through Spain, Portugal, France
- Indian business titan Ratan Tata dead at 86
- Fed minutes highlight divisions over rate cut decision
- Steve McQueen debuts new WWII film at London festival
- Nobel winners hope protein work will spur 'incredible' breakthroughs
- What are proteins again? Nobel-winning chemistry explained
- AI steps into science limelight with Nobel wins
- Overshooting 1.5C risks 'irreversible' climate impact: study
- Demis Hassabis, from chess prodigy to Nobel-winning AI pioneer
- Global stocks diverge as Chinese shares tumble
- Time runs out in Florida to flee Hurricane Milton
- Chad issues warning ahead of more devastating floods
- Creator's death no bar to new 'Dragon Ball' products
- Chinese stocks tumble on lack of fresh stimulus
- Trio wins chemistry Nobel for protein design, prediction
- Braving war: Lebanon's 'badass' airline defies odds
- US weighs Google breakup in landmark trial
RBGPF | 4.03% | 63.35 | $ | |
RYCEF | 0% | 6.9 | $ | |
CMSC | 0.15% | 24.557 | $ | |
BCC | -2.88% | 138.41 | $ | |
SCS | -3.7% | 12.565 | $ | |
BTI | -0.97% | 35.14 | $ | |
AZN | -0.99% | 76.745 | $ | |
NGG | 0.14% | 65.72 | $ | |
RIO | 0.53% | 66.705 | $ | |
GSK | -2.85% | 39.125 | $ | |
RELX | -0.77% | 46.355 | $ | |
JRI | -0.1% | 13.207 | $ | |
VOD | -0.31% | 9.7 | $ | |
BCE | -1.71% | 32.75 | $ | |
BP | 0.9% | 32.27 | $ | |
CMSD | 0.27% | 24.746 | $ |
Most baby formula health claims not backed by science: study
The vast majority of health claims used to advertise baby formula worldwide are not supported by rigorous scientific evidence, a study said Thursday, leading researchers to urge the breast milk substitutes be sold in plain packaging.
The study comes a week after a group of doctors and scientists called for a regulatory crackdown on the $55-billion formula industry for "predatory" marketing which they said exploits the fears of new parents to convince them not to breastfeed.
Breastfeeding is widely recognised to have huge health benefits for babies. The World Health Organization and the US CDC recommend breastfeeding exclusively during the first six months of a newborn's life.
However that recommendation is followed for less than half of infants globally, according to the WHO.
Daniel Munblit, an honorary senior lecturer at Imperial College London and an author of the new study, said researchers were not on a "crusade" against infant formula, which should remain an option for mothers who cannot or choose not to breastfeed.
"But we are very much against inappropriate infant formula marketing, which provides misleading claims not backed up by solid evidence," Munblit told AFP.
Munblit and an international team of researchers looked at the health claims made for 608 products on the websites of infant formula companies in 15 countries, including the United States, India, Britain and Nigeria.
The most common claims were that formula supports brain development, strengthens immune systems and more broadly helps growth.
Half of the products did not link the claimed health benefit to a specific ingredient, according to the study published in the BMJ journal.
Three quarters did not refer to scientific evidence supporting their claims.
Of those that provided a scientific reference, more than half pointed to reviews, opinion pieces or research on animals.
Just 14 percent of the products referred to registered clinical trials on humans. However 90 percent of those trials carried a high risk of bias, including missing data or the finding not supporting the claim, the study said.
And nearly 90 percent of the clinical trials had authors who received funding from or had ties to the formula industry, it added.
- 'Distressing' -
The most commonly cited ingredient was polyunsaturated fatty acids, which is in breast milk and is considered important for brain development.
However there is no evidence of any added benefit when the ingredient is added to baby formula, according to a Cochrane systematic review.
Munblit said the health claims were mostly used to advertise premium formula products, which could be "distressing" for parents who are misled into believing the ingredients are essential but cannot afford them.
When asked what he thinks needs to be done to address the problem, Munblit was concise.
"Plain packaging," he said.
The study comes after a series of papers were published in the Lancet journal last week calling for global policy makers to end exploitative formula marketing.
WHO infant health specialist Nigel Rollins, an author of one of the Lancet papers, said busy parents "lack the time to properly scrutinise claims" about infant formula.
The new study showed that "governments and regulatory authorities must commit the necessary time and attention to review the claims of formula milk products," Rollins said in a linked BMJ editorial.
Y.Jeong--CPN